Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stroke

  Free Subscription

Articles published in
Int J Cardiol
    November 2023
  1. CEMIN R, Maggioni AP, Boriani G, Di Pasquale G, et al
    Is there a reduced confidence towards direct oral anticoagulants compared to vitamin K antagonists in patients scheduled for an elective electrical cardioversion? The results of the BLITZ-AF study.
    Int J Cardiol. 2023;391:131302.
    >> Share

    October 2023
  2. CHEN X
    The real world of stroke incidence in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;388:131172.
    >> Share

    September 2023
  3. EMMERT-FEES KMF, Luhar S, O'Flaherty M, Kypridemos C, et al
    Forecasting the mortality burden of coronary heart disease and stroke in Germany: National trends and regional inequalities.
    Int J Cardiol. 2023 Sep 25:131359. doi: 10.1016/j.ijcard.2023.131359.
    >> Share

  4. HE D, Qin K, Li J, Li Y, et al
    Increased incidence risks of cardiovascular disease among cancer patients: Evidence from a population-based cohort study in China.
    Int J Cardiol. 2023 Sep 16:131362. doi: 10.1016/j.ijcard.2023.131362.
    >> Share

  5. GENNARO N, Ferroni E, Zorzi M, Denas G, et al
    ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAIVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
    Int J Cardiol. 2023 Sep 16:131369. doi: 10.1016/j.ijcard.2023.131369.
    >> Share

  6. MADIAS JE
    Heightened risk of ischemic stroke and mortality in takotsubo syndrome: A function of what?
    Int J Cardiol. 2023 Sep 6:131348. doi: 10.1016/j.ijcard.2023.131348.
    >> Share

  7. FUJII T, Kasai S, Kawamura Y, Yoshimachi F, et al
    Temporal variations in ischemic and bleeding event risks after acute coronary syndrome during dual antiplatelet therapy.
    Int J Cardiol. 2023 Sep 5:131340. doi: 10.1016/j.ijcard.2023.131340.
    >> Share

    August 2023
  8. EFTEKHARI A, van de Hoef TP, Hoshino M, Lee JM, et al
    Changes in microvascular resistance following percutaneous coronary intervention - From the ILIAS global registry.
    Int J Cardiol. 2023 Aug 25:131296. doi: 10.1016/j.ijcard.2023.131296.
    >> Share

  9. SHIMIZU W, Uchiyama S, Atarashi H, Inoue H, et al
    Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study.
    Int J Cardiol. 2023 Aug 22:131290. doi: 10.1016/j.ijcard.2023.131290.
    >> Share

  10. JESSEN N, Andersen JA, Tayal B, Ostergaard L, et al
    Takotsubo syndrome and stroke risk: A nationwide register-based study.
    Int J Cardiol. 2023 Aug 22:131283. doi: 10.1016/j.ijcard.2023.131283.
    >> Share

  11. GENTILE F, Buoncristiani F, Sciarrone P, Bazan L, et al
    Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation.
    Int J Cardiol. 2023 Aug 19:131272. doi: 10.1016/j.ijcard.2023.131272.
    >> Share

  12. CHO Y, Ueda T, Kotani S, Okada K, et al
    AATS 2023: Left ventricular restoration with scar exclusion in the surgical treatment for ischemic heart failure.
    Int J Cardiol. 2023 Aug 18:131277. doi: 10.1016/j.ijcard.2023.131277.
    >> Share

  13. PIERONI M, Ciabatti M, Bolognese L
    Stroke in hypertrophic cardiomyopathy. Never mind the rhythm.
    Int J Cardiol. 2023;385:41-42.
    >> Share

  14. DAVIES A, Wenzl FA, Li XS, Winzap P, et al
    Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes.
    Int J Cardiol. 2023 Aug 11:131261. doi: 10.1016/j.ijcard.2023.131261.
    >> Share

  15. POORTHUIS MHF, Sherliker P, de Borst GJ, Clack R, et al
    Detection rates of asymptomatic carotid stenosis and atrial fibrillation by selective screening of patients without cardiovascular disease.
    Int J Cardiol. 2023 Aug 11:131262. doi: 10.1016/j.ijcard.2023.131262.
    >> Share

    July 2023
  16. AMADIO P, Porro B, Cavalca V, Zara M, et al
    Hemostatic system in Takotsubo patients at long-term follow-up: A hidden activation?
    Int J Cardiol. 2023 Jul 30:131229. doi: 10.1016/j.ijcard.2023.131229.
    >> Share

  17. PAPAPOSTOLOU S, Kearns J, Costello BT, O'Brien J, et al
    Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source.
    Int J Cardiol. 2023 Jul 25:131215. doi: 10.1016/j.ijcard.2023.131215.
    >> Share

  18. LIN H, Chang Y, Zhou H, Li J, et al
    Early results of frozen elephant trunk in acute type-A dissection in 1445 patients.
    Int J Cardiol. 2023 Jul 25:131213. doi: 10.1016/j.ijcard.2023.131213.
    >> Share

  19. TOSO E, De Lio F, Bocchino PP, Raineri C, et al
    Risk of cardioembolic ischemic events and relation to atrial fibrillation/flutter in patients with arrhythmogenic cardiomyopathy during a long-term follow-up.
    Int J Cardiol. 2023 Jul 21:131200. doi: 10.1016/j.ijcard.2023.131200.
    >> Share

  20. BHOGAL S, Rogers T, Merdler I, Reddy P, et al
    Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Jul 19:131196. doi: 10.1016/j.ijcard.2023.131196.
    >> Share

  21. MELILLO F, Leo G, Parlati ALM, Gaspardone C, et al
    Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes.
    Int J Cardiol. 2023 Jul 13:131188. doi: 10.1016/j.ijcard.2023.131188.
    >> Share

    June 2023
  22. LIND A, Esfahan MA, Totzeck M, Al-Rashid F, et al
    Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.
    Int J Cardiol. 2023 Jun 22:131130. doi: 10.1016/j.ijcard.2023.131130.
    >> Share

  23. TRABATTONI D, Gili S, Calligaris G, Teruzzi G, et al
    Patent foramen ovale closure with the Occlutech Figulla flex II device: A long-term (up to 10-years) follow-up.
    Int J Cardiol. 2023 Jun 8:131116. doi: 10.1016/j.ijcard.2023.
    >> Share

    May 2023
  24. ZHOU L, Li Y, Yang X, Gu H, et al
    Effect of prior anticoagulation therapy on stroke severity and in-hospital outcomes in patients with acute ischemic stroke and atrial fibrillation.
    Int J Cardiol. 2023 May 29:S0167-5273(23)00745.
    >> Share

  25. SHADAREVIAN J, Zhu K, Kwan JM, Wan D, et al
    Arrhythmic and thromboembolic outcomes in adults with coarctation of the aorta.
    Int J Cardiol. 2023 May 29:S0167-5273(23)00741.
    >> Share

  26. FAGUNDES A JR, Ruff CT, Morrow DA, Murphy SA, et al
    Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial.
    Int J Cardiol. 2023 May 19:S0167-5273(23)00724.
    >> Share

  27. PENG S, Liu X, Cao W, Liu Y, et al
    Global, regional, and national time trends in mortality for stroke, 1990-2019: An age-period-cohort analysis for the global burden of disease 2019 study and implications for stroke prevention.
    Int J Cardiol. 2023 May 5:S0167-5273(23)00652.
    >> Share

    April 2023
  28. SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
    Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
    Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
    >> Share

  29. NI Y
    Letter the editor: Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States.
    Int J Cardiol. 2023;377:51.
    >> Share

  30. FUMAGALLI C, Bonanni F, Beltrami M, Ruggieri R, et al
    Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
    Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523.
    >> Share

  31. LEIBOWITZ D, Yoshida Y, Jin Z, Nakanishi K, et al
    Factors associated with the progression of aortic valve calcification in older adults.
    Int J Cardiol. 2023 Apr 6:S0167-5273(23)00470.
    >> Share

  32. LIU Y, Zheng Y, Tse G, Bazoukis G, et al
    Association between sick sinus syndrome and atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Apr 4:S0167-5273(23)00477.
    >> Share

    March 2023
  33. DENEGRI A, Magnani G, Kraler S, Bruno F, et al
    History of peripheral artery disease and cardiovascular risk of real-word patients with acute coronary syndrome: Role of inflammation and comorbidities.
    Int J Cardiol. 2023 Mar 21:S0167-5273(23)00454.
    >> Share

  34. TROISI F, Guida P, Vitulano N, Quadrini F, et al
    Safety and efficacy of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation electrical cardioversion: An update systematic review and meta-analysis.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00394.
    >> Share

  35. ESPOSITO G, Montalto C, Crimi G, Grippo R, et al
    Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE registry).
    Int J Cardiol. 2023 Mar 8:S0167-5273(23)00336.
    >> Share

  36. ZHANG W, Wang F
    Could carotid screening cause more harm than good?
    Int J Cardiol. 2023;374:115.
    >> Share

    February 2023
  37. D'ASCENZO F, Bruno F, Iannaccone M, Testa G, et al
    Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00256.
    >> Share

  38. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    >> Share

  39. CHEN J, Lv M, Xu W, Zhang F, et al
    New score for predicting major bleeding in patients with atrial fibrillation using direct oral anticoagulants.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00233.
    >> Share

  40. HAUM M, Humpfer F, Steffen J, Fischer J, et al
    Quantification of physical activity with prospective activity tracking after transfemoral aortic valve replacement.
    Int J Cardiol. 2023 Feb 7:S0167-5273(23)00168.
    >> Share

    January 2023
  41. YOSHII T, Matsuzawa Y, Kato S, Sato R, et al
    Endothelial dysfunction predicts bleeding and cardiovascular death in acute coronary syndrome.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00121.
    >> Share

  42. MELONI A, Gargani L, Bruni C, Cavallaro C, et al
    Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma.
    Int J Cardiol. 2023 Jan 30:S0167-5273(23)00105.
    >> Share

  43. PARASKEVAS KI, Nicolaides AN, Spence JD, Mikhailidis DP, et al
    Clarifying the rationale supporting selective screening for asymptomatic carotid artery stenosis.
    Int J Cardiol. 2023 Jan 18:S0167-5273(23)00069.
    >> Share

  44. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Reply to: Among patients with MINOCA women versus men have the increased risks of MACE and stroke?
    Int J Cardiol. 2023;371:80-81.
    >> Share

  45. VIGNALI L, Gurgoglione FL, Barocelli F, Cattabiani MA, et al
    Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens.
    Int J Cardiol. 2023;371:92-99.
    >> Share

  46. ABRAHAMYAN L, Barker M, Dharma C, Lee DS, et al
    Real world long-term outcomes among adults undergoing transcatheter patent foramen closure with amplatzer PFO occluder.
    Int J Cardiol. 2023;371:109-115.
    >> Share

  47. PARASKEVAS KI, Spence JD, Mikhailidis DP, Antignani PL, et al
    Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A plea for a randomized controlled trial.
    Int J Cardiol. 2023;371:406-412.
    >> Share

  48. XU C, Meng J
    Is rivaroxaban an all-rounder?
    Int J Cardiol. 2023;371:228.
    >> Share

  49. DU L, Wang P, Chen H, Zhang Y, et al
    Among patients with MINOCA women versus men have the increased risks of MACE and stroke?
    Int J Cardiol. 2023;371:82.
    >> Share

  50. FUJII T, Endo S, Tsuchiya R, Nagamatsu H, et al
    Estimation of adverse events associated with P2Y12 receptor inhibitors stratified by academic research consortium for high bleeding risk criteria in acute coronary syndrome.
    Int J Cardiol. 2023 Jan 14:S0167-5273(23)00061.
    >> Share

  51. TANG SC, Liu YB, Lin LY, Huang HC, et al
    Association between atrial fibrillation burden and cognitive function in patients with atrial fibrillation.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00049.
    >> Share

  52. POORTHUIS MHF, Kappelle LJ, de Borst GJ
    A research agenda for selective screening for asymptomatic carotid artery stenosis.
    Int J Cardiol. 2023;370:421-422.
    >> Share

  53. ABTAN J, Bhatt DL, Elbez Y, Ducrocq G, et al
    External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued
    Int J Cardiol. 2023;370:51-57.
    >> Share

  54. GALLI M, Benenati S, Zito A, Capodanno D, et al
    Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis.
    Int J Cardiol. 2023;370:58-64.
    >> Share

    December 2022
  55. GALIMZHANOV A, Sabitov Y, Guclu E, Tenekecioglu E, et al
    Phenotyping for percutaneous coronary intervention and long-term recurrent weighted outcomes.
    Int J Cardiol. 2022 Dec 24:S0167-5273(22)01919.
    >> Share

  56. BORIANI G, Imberti JF, Vitolo M
    Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target.
    Int J Cardiol. 2022 Dec 11:S0167-5273(22)01895.
    >> Share

  57. MORTBERG J, Salzinger B, Lundwall K, Edfors R, et al
    Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function.
    Int J Cardiol. 2022 Dec 4:S0167-5273(22)01876.
    >> Share

    November 2022
  58. VAN BERGEIJK KH, Wykrzykowska JJ, Sartori S, Snyder C, et al
    Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01743.
    >> Share

  59. PARASKEVAS KI, Eckstein HH, Mansilha A, Ricco JB, et al
    Screening for asymptomatic carotid stenosis in patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2022 Nov 23:S0167-5273(22)01724.
    >> Share

  60. SIUDUT J, Pudlo J, Konieczynska M, Polak M, et al
    Therapy with high-dose statins reduces soluble P-selectin: The impact on plasma fibrin clot properties.
    Int J Cardiol. 2022 Nov 21:S0167-5273(22)01713.
    >> Share

  61. CAU R, Pisu F, Porcu M, Cademartiri F, et al
    Machine learning approach in diagnosing Takotsubo cardiomyopathy: The role of the combined evaluation of atrial and ventricular strain, and parametric mapping.
    Int J Cardiol. 2022 Nov 18:S0167-5273(22)01708.
    >> Share

  62. ZUERCHER MD, Harvey DJ, Au LE, Shadyab AH, et al
    Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women.
    Int J Cardiol. 2022;367:99-104.
    >> Share

  63. BERRETTA P, De Angelis V, Alfonsi J, Pierri MD, et al
    Enhanced recovery after minimally invasive heart valve surgery: Early and midterm outcomes.
    Int J Cardiol. 2022 Nov 12:S0167-5273(22)01703.
    >> Share

  64. HAMATANI Y, Kato T, Morimoto T, Iguchi M, et al
    Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure.
    Int J Cardiol. 2022 Nov 11. pii: S0167-5273(22)01705.
    >> Share

  65. BOERHOUT CKM, de Waard GA, Lee JM, Mejia-Renteria H, et al
    Combined use of hyperemic and non-hyperemic pressure ratios for revascularization decision-making: From the ILIAS registry.
    Int J Cardiol. 2022 Nov 11:S0167-5273(22)01702.
    >> Share

  66. KRITTANAWONG C, Yue B, Khawaja M, Kumar A, et al
    Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States.
    Int J Cardiol. 2022 Nov 7. pii: S0167-5273(22)01646.
    >> Share

  67. CAI J, Zhang L, Chen C, Ge J, et al
    Association between serum klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007-2016.
    Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01697.
    >> Share

  68. JOLOBE OMP
    Screening for high-grade asymptomatic carotid artery stenosis in nonvalvular atrial fibrillation.
    Int J Cardiol. 2022 Nov 4. pii: S0167-5273(22)01691.
    >> Share

  69. DU L, Zhang Y, Wang P, Li Z, et al
    GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?
    Int J Cardiol. 2022;366:31.
    >> Share

    October 2022
  70. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
    Screening for atrial fibrillation to prevent stroke in elderly individuals with or without preexisting cardiovascular disease: A post hoc analysis of the randomized LOOP study.
    Int J Cardiol. 2022 Oct 31. pii: S0167-5273(22)01678.
    >> Share

  71. VANDENBRIELE C, Van Edom C, Tavazzi G
    Anticoagulant management for transition from failed thrombolysis to extra-corporeal membrane oxygenation in patients with high-risk pulmonary embolism: A thoughtful approach.
    Int J Cardiol. 2022 Oct 22. pii: S0167-5273(22)01649.
    >> Share

  72. OLIVERI F, Montalto C, Tua L, Lanzillo G, et al
    Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysis.
    Int J Cardiol. 2022;365:123-130.
    >> Share

  73. MENG Y, Zhang Y, Zhu C, Nie C, et al
    Atrial high-rate episode burden and stroke risks for patients with device-detected subclinical atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Oct 12. pii: S0167-5273(22)01398.
    >> Share

  74. JIANG N, Wang Z, Deng Q, Zhou Y, et al
    Low-intensity focused ultrasound guided dodecafluoropentane-loaded acoustic phase-change nanoparticles for treatment of porcine coronary microthromboembolism.
    Int J Cardiol. 2022 Oct 5. pii: S0167-5273(22)01465.
    >> Share

  75. XU W, Lv M, Wu T, Huang N, et al
    Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose.
    Int J Cardiol. 2022 Oct 5. pii: S0167-5273(22)01460.
    >> Share

    September 2022
  76. MAI AS, Matetic A, Elgendy IY, Mattei JL, et al
    The Association Between Cancer Diagnosis, Care, and Outcomes in 1 Million Patients Hospitalized for Acute Pulmonary Embolism.
    Int J Cardiol. 2022 Sep 24. pii: S0167-5273(22)01399.
    >> Share

  77. SOKHAL BS, Matetic A, Paul TK, Velagapudi P, et al
    Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01387.
    >> Share

  78. LERMAN TT, Levi A, Kornowski R
    Meta-analysis of short- and long-term clinical outcomes of the self-expanding Evolut R/pro valve versus the balloon-expandable Sapien 3 valve for transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01385.
    >> Share

  79. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    >> Share

  80. VERGARO G, Aimo A, Castiglione V, Emdin M, et al
    Stroke in ATTR cardiac amyloidosis: Does only rhythm matter?
    Int J Cardiol. 2022;363:127-128.
    >> Share

  81. LETSAS KP, Saplaouras A
    Atrial fibrillation ablation combined with left atrial appendage occlusion: Optimal patient selection should be the main focus.
    Int J Cardiol. 2022 Sep 9. pii: S0167-5273(22)01323.
    >> Share

  82. PEREIRA MQ, David C, Almeida AG, Brito D, et al
    Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis.
    Int J Cardiol. 2022;362:76-82.
    >> Share

    August 2022
  83. HWANG IC, Kim CH
    Reply to "GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?"
    Int J Cardiol. 2022 Aug 23. pii: S0167-5273(22)01257.
    >> Share

  84. IWAKAWA H, Terata K, Kato R, Kaimori R, et al
    Utility of P-wave abnormalities for distinguishing embolic stroke from non-embolic stroke.
    Int J Cardiol. 2022 Aug 23. pii: S0167-5273(22)01247.
    >> Share

  85. CHEN M, Sun J, Wang QS, Zhang PP, et al
    Long-term outcome of combined catheter ablation and left atrial appendage closure in atrial fibrillation patients.
    Int J Cardiol. 2022 Aug 8. pii: S0167-5273(22)01174.
    >> Share

  86. BRUNS F, Dobrev D, Fender AC
    Persisting stroke risk in patients with atrial fibrillation despite proper anticoagulation - Unmet clinical needs.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01186.
    >> Share

  87. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01120.
    >> Share

    July 2022
  88. DE LUCA G, Verdoia M, Morici N, Ferri LA, et al
    Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial.
    Int J Cardiol. 2022 Jul 27. pii: S0167-5273(22)01104.
    >> Share

  89. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    >> Share

  90. MOLEK P, Chmiel J, Zabczyk M, Malinowski KP, et al
    Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01103.
    >> Share

  91. DIXON LK, Akberali U, Di Tommaso E, George SJ, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022;359:20-27.
    >> Share

  92. GOEL A, Singhal M, Malik AH, Gupta R, et al
    Patent foramen ovale closure for recurrent stroke prevention: Recent evidence towards individualized decision-making.
    Int J Cardiol. 2022;358:25.
    >> Share

    June 2022
  93. KORSHOLM K, Valentin JB, Damgaard D, Diener HC, et al
    Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Int J Cardiol. 2022 Jun 30. pii: S0167-5273(22)01019.
    >> Share

  94. BAKER HE, Tune JD, Mather KJ, Blaettner BS, et al
    Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na+/H+ exchanger-1.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01006.
    >> Share

  95. KIM CH, Hwang IC, Choi HM, Ahn CH, et al
    Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00927.
    >> Share

  96. KANY S, Kuck KH, Brachmann J, Andresen D, et al
    Outcomes in patients experiencing complications associated with atrial fibrillation ablation: Data from the German ablation registry.
    Int J Cardiol. 2022 Jun 12. pii: S0167-5273(22)00918.
    >> Share

    May 2022
  97. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    >> Share

  98. PRACON R, Zielinski K, Bangalore S, Konka M, et al
    Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Int J Cardiol. 2022;354:17-21.
    >> Share

    April 2022
  99. DALE Z, Chandrashekar P, Al-Rashdan L, Gill S, et al
    Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosis.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00559.
    >> Share

  100. XUE W, Tian Y, Jing L, Li R, et al
    Sex difference in the correlation between carotid artery diameter and prevalence of stroke: Insights from a Chinese population.
    Int J Cardiol. 2022;353:103-108.
    >> Share

  101. JOLOBE OMP
    Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00509.
    >> Share

  102. LI L, Dai M, Fu Y
    Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00508.
    >> Share

  103. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    >> Share

    March 2022
  104. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    >> Share

  105. SADEGHIPOUR P, Pouraliakbar H, Parsaee M, Shojaeifard M, et al
    RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00396.
    >> Share

    February 2022
  106. MAGNANI G, Bricoli S, Ardissino M, Maglietta G, et al
    Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00249.
    >> Share

  107. GONZALEZ PEREZ A, Balabanova Y, Saez ME, Brobert G, et al
    Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom.
    Int J Cardiol. 2022 Feb 2. pii: S0167-5273(22)00190.
    >> Share

  108. ORSINI E, Marzilli M, Zito GB, Carbone V, et al
    Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study.
    Int J Cardiol. 2022 Feb 1. pii: S0167-5273(22)00182.
    >> Share

    January 2022
  109. LI X, Jia Z, Yan Y
    Ticagrelor for prevention of stroke and cognitive impairment in patients with vascular high-risk factors: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 Jan 31. pii: S0167-5273(22)00186.
    >> Share

  110. FU EL, Clase CM, Janse RJ, Lindholm B, et al
    Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00131.
    >> Share

    December 2021
  111. HUANG CK, Wang JC, Chung CH, Chen SJ, et al
    The risk and timing of acute ischemic stroke after electrical cardioversion for atrial fibrillation in Taiwan: A nationwide population-based cohort study.
    Int J Cardiol. 2021 Dec 23. pii: S0167-5273(21)02038.
    >> Share

  112. D'ANCONA G, Arslan F, Safak E, Weber D, et al
    Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation.
    Int J Cardiol. 2021 Dec 17. pii: S0167-5273(21)02019.
    >> Share

  113. DI LULLO L, Lavalle C, Magnocavallo M, Mariani MV, et al
    New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation.
    Int J Cardiol. 2021;345:90-97.
    >> Share

  114. BONAVENTURA A
    Assisted reproductive technologies and stroke: Risk factor, predictor of poor outcome, or both?
    Int J Cardiol. 2021;344:220-221.
    >> Share

    November 2021
  115. TANG Y, Liu S, Shi Y, He T, et al
    Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction.
    Int J Cardiol. 2021 Nov 24. pii: S0167-5273(21)01861.
    >> Share

  116. RAHMAN MU, Amritphale A, Kumar S, Trice C, et al
    Assessment of independent clinical predictors of early readmission after percutaneous endoluminal left atrial appendage closure with the Watchman device using National Readmission Database.
    Int J Cardiol. 2021;343:21-26.
    >> Share

  117. BONETTI NR, Meister TA, Soria R, Akhmedov A, et al
    In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.
    Int J Cardiol. 2021;343:92-101.
    >> Share

  118. MARSTON XL, Wang R, Yeh YC, Zimmermann L, et al
    Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study.
    Int J Cardiol. 2021 Nov 12. pii: S0167-5273(21)01776.
    >> Share

  119. ZHENG X, Wang F, Zhang J, Cui X, et al
    Using machine learning to predict atrial fibrillation diagnosed after ischemic stroke.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01773.
    >> Share

  120. SILVERIO A, Di Maio M, Buccheri S, De Luca G, et al
    Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01784.
    >> Share

    September 2021
  121. RADINOVIC A, Falasconi G, Marzi A, D'Angelo G, et al
    Long-term outcome of left atrial appendage occlusion with multiple devices.
    Int J Cardiol. 2021 Sep 29. pii: S0167-5273(21)01492.
    >> Share

  122. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    >> Share

  123. SHANG L, Sun H, Tang B
    Screening for atrial fibrillation in older populations: Outcome is more important than detection.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01486.
    >> Share

  124. SPARROW RT, Sanjoy SS, Lindman BR, Tang GHL, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing transcatheter mitral edge-to-edge repair.
    Int J Cardiol. 2021 Sep 20. pii: S0167-5273(21)01478.
    >> Share

  125. AIT-OUFELLA H, Yu M, Kotti S, Georges A, et al
    Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 study.
    Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01379.
    >> Share

  126. AL-RUBAISH AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, et al
    Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01319.
    >> Share

  127. ANDERSEN P, Kragholm K, Torp-Pedersen C, Jensen SE, et al
    The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.
    Int J Cardiol. 2021 Sep 6. pii: S0167-5273(21)01321.
    >> Share

    August 2021
  128. WANG W, Liu Y, Liu J, Yin P, et al
    Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: Empirical evidence from national mortality surveillance system.
    Int J Cardiol. 2021 Aug 25. pii: S0167-5273(21)01300.
    >> Share

  129. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    >> Share

  130. SEN J, Tonkin A, Varigos J, Fonguh S, et al
    Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.
    Int J Cardiol. 2021;337:9-15.
    >> Share

  131. ZUIN M, Rigatelli G
    Thrombus straddling a patent foramen ovale: Also a myocardial infarction matter?
    Int J Cardiol. 2021 Aug 7. pii: S0167-5273(21)01206.
    >> Share

    July 2021
  132. JAMAL J, O'Loughlin A, French JK
    A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Jul 31. pii: S0167-5273(21)01210.
    >> Share

  133. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    >> Share

  134. JACOBSEN MR, Engstrom T, Torp-Pedersen C, Gislason G, et al
    Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01192.
    >> Share

  135. NEDIOS S
    Screening for atrial fibrillation: Does cardiovascular disease reduce the probability of detection?
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01097.
    >> Share

  136. VEDOVATI MC, Tratar G, Mavri A, Mazzetti M, et al
    Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01099.
    >> Share

  137. SHAH P, Jimenez-Ruiz A, Gibson A, Vargas-Gonzalez JC, et al
    Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01101.
    >> Share

    June 2021
  138. VAN DER MATEN G, Dijkstra S, Meijs MFL, von Birgelen C, et al
    Cardiac imaging in ischemic stroke or transient ischemic attack of undetermined cause: Systematic review & meta-analysis.
    Int J Cardiol. 2021 Jun 28. pii: S0167-5273(21)01083.
    >> Share

  139. FAROUX L, Cruz-Gonzalez I, Arzamendi D, Freixa X, et al
    Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Int J Cardiol. 2021;333:77-82.
    >> Share

    May 2021
  140. JANSSENS GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, et al
    Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome.
    Int J Cardiol. 2021 May 15. pii: S0167-5273(21)00830.
    >> Share

  141. MINHAS A, Shade JK, Cho SM, Michos ED, et al
    The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19.
    Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00823.
    >> Share

  142. MANNINA C, Jin Z, Matsumoto K, Ito K, et al
    Frequency of cardiac arrhythmias in older adults: Findings from the Subclinical Atrial Fibrillation and Risk of Ischemic Stroke (SAFARIS) study.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00818.
    >> Share

  143. MIRO O, Llorens P, Jimenez S, Pinera P, et al
    Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.
    Int J Cardiol. 2021;330:268-272.
    >> Share

  144. SHIN SY, Park JW
    Is the Left Atrial Appendage (LAA) anatomical shape really meaningless measure for stroke risk assessment?
    Int J Cardiol. 2021;330:80-81.
    >> Share

    April 2021
  145. LANGER A, Healey JS, Quinn FR, Honos G, et al
    Detection of atrial fibrillation in asymptomatic at-risk individuals.
    Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00737.
    >> Share

  146. ELGENDY IY, Mansoor H, Pepine CJ
    Reproductive lifespan and incident stroke risk among post-menopausal women: Is it time for sex-specific risk prediction tools?
    Int J Cardiol. 2021;328:218-219.
    >> Share

  147. MISHRA SR, Waller M, Chung HF, Mishra GD, et al
    Association of the length of oestrogen exposure with risk of incident stroke in postmenopausal women: Insights from a 20-year prospective study.
    Int J Cardiol. 2021;328:206-214.
    >> Share

    March 2021
  148. GAWALKO M, Dobrev D
    Oral anticoagulation and therapy of atrial flutter: discontinuation of anticoagulation revisited.
    Int J Cardiol. 2021 Mar 17. pii: S0167-5273(21)00479.
    >> Share

  149. STRAW S, Witte KK
    Closing the loop: Delivering personalised care for patients with cryptogenic stroke.
    Int J Cardiol. 2021;327:100-101.
    >> Share

  150. KRISHNAPPA D, Wang W, Rooney MR, Norby FL, et al
    Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00394.
    >> Share

  151. DE HEIDE J, de Wit A, Bhagwandien RE, Assaf A, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population.
    Int J Cardiol. 2021;326:98-102.
    >> Share

    February 2021
  152. GIEHM-REESE M, Johansen MN, Kronborg MB, Jensen HK, et al
    Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study.
    Int J Cardiol. 2021 Feb 27. pii: S0167-5273(21)00366.
    >> Share

  153. KOZIEL M, Mihajlovic M, Nedeljkovic M, Pavlovic N, et al
    Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00294.
    >> Share

  154. COWAN LT, Buck B, Schwind JS, Lutsey PL, et al
    Triggering of cardiovascular disease by infection type: The Atherosclerosis Risk in Communities study (ARIC).
    Int J Cardiol. 2021;325:155-160.
    >> Share

  155. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    >> Share

    January 2021
  156. HARIHARAN P, Giordano N, Muzikansky A, Kabrhel C, et al
    Clinical factors associated with massive pulmonary embolism and PE-related adverse clinical events.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00139.
    >> Share

  157. KALARIA SN, Zhu H, Liu Q, Florian J, et al
    Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00106.
    >> Share

  158. DUDZINSKA-SZCZERBA K, Michalowska I, Piotrowski R, Sikorska A, et al
    Assessment of the left atrial appendage morphology in patients after ischemic stroke - The ASSAM study.
    Int J Cardiol. 2021 Jan 29. pii: S0167-5273(21)00080.
    >> Share

  159. ZWEIKER D, Manninger M, Sieghartsleitner R, Ebner J, et al
    No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
    Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00082.
    >> Share

  160. DE ROQUETAILLADE C, Chousterman BG, Tomasoni D, Zeitouni M, et al
    Unusual arterial thrombotic events in Covid-19 patients.
    Int J Cardiol. 2021;323:281-284.
    >> Share

  161. HWANG J, Lee SR, Park HS, Lee YS, et al
    Adherence to dabigatran and the influence of dabigatran-induced gastrointestinal discomfort in the real-world practice.
    Int J Cardiol. 2021;323:77-82.
    >> Share

  162. GU K, Mahtta D, Kaneria A, Sharedalal P, et al
    Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR(R) PINNACLE Registry.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34312.
    >> Share

  163. SCOGNAMIGLIO G, Fusco F, Hankel TC, Bouma BJ, et al
    Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.
    Int J Cardiol. 2021;322:129-134.
    >> Share

    December 2020
  164. FEMIA G, Zhu D, Choudhary P, Ross SB, et al
    Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults.
    Int J Cardiol. 2020 Dec 10. pii: S0167-5273(20)34265.
    >> Share

  165. LENG WX, Yang JG, Li XD, Jiang WY, et al
    Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
    Int J Cardiol. 2020 Dec 8. pii: S0167-5273(20)34245.
    >> Share

  166. CAPIAU A, De Backer T, Grymonprez M, Lahousse L, et al
    Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and EHRA Practical Guide.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34231.
    >> Share

    November 2020
  167. KOBO O, Contractor T, Mohamed MO, Parwani P, et al
    Impact of pre-existent vascular and poly-vascular disease on acute myocardial infarction management and outcomes: An analysis of 2 million patients from the National Inpatient Sample.
    Int J Cardiol. 2020 Nov 30. pii: S0167-5273(20)34220.
    >> Share

  168. CASU G, D'Angelo G, Ugo F, Ronco F, et al
    Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study.
    Int J Cardiol. 2020 Nov 24. pii: S0167-5273(20)34168.
    >> Share

  169. DOMINGUEZ-ERQUICIA P, Raposeiras-Roubin S, Abbu-Assi E, Cespon-Fernandez M, et al
    Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation.
    Int J Cardiol. 2020 Nov 18. pii: S0167-5273(20)34146.
    >> Share

  170. MARKS D, Ho R, Then R, Weinstock JL, et al
    Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence.
    Int J Cardiol. 2020 Nov 10. pii: S0167-5273(20)34140.
    >> Share

  171. ANDERSSON T, Aspberg S
    Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study.
    Int J Cardiol. 2020 Nov 2. pii: S0167-5273(20)34068.
    >> Share

    October 2020
  172. VALLABHAJOSYULA S
    Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
    Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.
    >> Share

  173. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
    Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
    Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
    >> Share

  174. FENDER AC, Dobrev D
    The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation.
    Int J Cardiol. 2020 Oct 1. pii: S0167-5273(20)33897.
    >> Share

    September 2020
  175. PACHOLCZAK-MADEJ R, Bazan-Socha S, Zareba L, Undas A, et al
    Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study.
    Int J Cardiol. 2020 Sep 12. pii: S0167-5273(20)33818.
    >> Share

    August 2020
  176. CHANTRARAT T, Krittayaphong R
    Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population,Data from the COOL-AF Thailand registry.
    Int J Cardiol. 2020 Aug 20. pii: S0167-5273(20)33651.
    >> Share

  177. LIU J, Wang Y, Guo W, Cheng Y, et al
    Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
    Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33573.
    >> Share

  178. RUTLAND J, Ayoub K, Etaee F, Ogunbayo G, et al
    CHA2DS2-VASc and readmission with new-onset atrial fibrillation, atrial flutter, or acute cerebrovascular accident.
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33554.
    >> Share

  179. MALAVASI VL, Zoccali C, Brandi MC, Micali G, et al
    Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study.
    Int J Cardiol. 2020 Aug 12. pii: S0167-5273(20)33555.
    >> Share

  180. CARRERO JJ, Trevisan M, Evans M, Svennberg E, et al
    Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation.
    Int J Cardiol. 2020 Aug 5. pii: S0167-5273(20)33530.
    >> Share

    July 2020
  181. LOPES RD, Berger SE, Di Fusco M, Kang A, et al
    A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation.
    Int J Cardiol. 2020 Jul 4. pii: S0167-5273(20)33439.
    >> Share

    June 2020
  182. HUANG J, Wu N, Xiang Y, Wu L, et al
    Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation.
    Int J Cardiol. 2020 Jun 27. pii: S0167-5273(20)33408.
    >> Share

  183. AKHTAR T, Fratti JDC, Mattumpuram J, Fugar S, et al
    Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience.
    Int J Cardiol. 2020 Jun 26. pii: S0167-5273(20)33410.
    >> Share

  184. PATTI G, Pecen L, Manu MC, Huber K, et al
    Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies.
    Int J Cardiol. 2020 Jun 20. pii: S0167-5273(20)33388.
    >> Share

    May 2020
  185. JAUME FP, Aleix OS, Nuria RG, Jordi PR, et al
    High incidence of subclinical atrial fibrillation in patients with syncope monitored with implantable cardiac monitor.
    Int J Cardiol. 2020 May 26. pii: S0167-5273(20)32451.
    >> Share

    April 2020
  186. PUGLIESE NR, Masi S
    Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease.
    Int J Cardiol. 2020 Apr 21. pii: S0167-5273(20)31424.
    >> Share

  187. GEARY L, Hasselstrom J, Carlsson AC, Schenck-Gustafsson K, et al
    An audit & feedback intervention for improved anticoagulant use in patients with atrial fibrillation in primary care.
    Int J Cardiol. 2020 Apr 12. pii: S0167-5273(20)30628.
    >> Share

    March 2020
  188. YUAN S, Lin A, He QQ, Burgess S, et al
    Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
    Int J Cardiol. 2020 Mar 21. pii: S0167-5273(20)30701.
    >> Share

  189. ZAKERI R, Morgan JM, Phillips P, Kitt S, et al
    Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2020 Mar 3. pii: S0167-5273(19)34926.
    >> Share

    February 2020
  190. NEDIOS S, Dobrev D
    Electrocardiographic sex-related differences in patients with atrial fibrillation: Do they allow a better risk stratification?
    Int J Cardiol. 2020 Feb 19. pii: S0167-5273(20)30218.
    >> Share

    January 2020
  191. BAE JH, Corban MT, Seo YH, Kim T, et al
    Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events.
    Int J Cardiol. 2020;299:26-30.
    >> Share

  192. RODRIGUEZ-CASTRO E, Hervella P, Lopez-Dequidt I, Arias-Rivas S, et al
    NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack.
    Int J Cardiol. 2020;298:93-97.
    >> Share

    December 2019
  193. BAHIT MC, Granger CB, Alexander JH, Mulder H, et al
    Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.
    Int J Cardiol. 2019 Dec 30. pii: S0167-5273(19)34634.
    >> Share

    October 2019
  194. LUCIJANIC M, Jurin I, Jurin H, Lucijanic T, et al
    Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.
    Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)34260.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016